Skip to main content
Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.82
+0.82 (3.42%)
At close: Mar 9, 2026, 4:00 PM EDT
24.70
-0.12 (-0.48%)
After-hours: Mar 9, 2026, 5:17 PM EDT

Arcutis Biotherapeutics Revenue

In the year 2025, Arcutis Biotherapeutics had annual revenue of $376.07M with 91.34% growth. Arcutis Biotherapeutics had revenue of $129.50M in the quarter ending December 31, 2025, with 81.48% growth.

Revenue (ttm)
$376.07M
Revenue Growth
+91.34%
P/S Ratio
7.99
Revenue / Employee
$1,062,350
Employees
354
Market Cap
3.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025376.07M179.53M91.34%
Dec 31, 2024196.54M136.94M229.74%
Dec 31, 202359.61M55.92M1,517.09%
Dec 31, 20223.69M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Catalyst Pharmaceuticals 588.99M
Tarsus Pharmaceuticals 451.36M
Arcus Biosciences 247.00M
IDEAYA Biosciences 218.71M
Viridian Therapeutics 70.85M
Dianthus Therapeutics 3.08M
Revenue Rankings

ARQT News

More News